yeah someone hacked in my account and i told all stocks and they closed my account and stopped using allstocks for a while but now i am back as of a couple of months ago
Posts: 1264 | Registered: Jul 2009
| IP: Logged |
quote:IMDS model 1020 CTLMlaser breast imaging system is the only technology that can perform an enhanced breast cancer screening on women with breast implants. This technology when utilized withthe fluorescent dye, Indocyanine Green (ICG), can provide accurate screening and avoid misdiagnosis and avoid death and unnecessary biopsy and breast removal. The Chinese government has ordered 75 machines and will negotiate to open a factory in Bejiing. With the boom in the economy Chinese women have out paced every other nation in breast agumentation surgery. The majority of these women are approaching the age which the Chinese government has imposed mandatory breast cancer screening. In the past, implants have caused an extraordinary number of false diagnosis and tragically unnecessary breast removal. IMDS new technology provides a vivid 3 dimensional view of breast tissue, even in breast obscured by implants and surgical scarring.
I can't find a press release or something, dunno where the poster got this from. But I can personally confirm the growing needs for breast augmentation!
And here's another one from July:
quote:IMDS: Breast Cancer Imaging Study Begins in Germany
Ridgeland, MS, JUL 15, 2009 (EventX/Knobias.com via COMTEX) -- IMDS | Quote | Chart | News | PowerRating -- By Fain Hughes, email@example.com Imaging Diagnostic Systems, Inc. (IMDS) announced the commencement of a breast cancer imaging study at the Charite, Medical University in Berlin, Germany. The study will examine the potential role of its model 1020 CTLM(R) laser breast imaging system as an enhanced breast cancer screening tool when used in combination with the fluorescent dye, Indocyanine Green (ICG).
The ICG fluorescent dye has a distribution pattern in the human body similar to that of extracellular MRI and CT contrast agents and it is already approved for other medical applications. The IDSI model 1020 CTLM scanner that will be used in the study has been specially modified to be able to both excite the ICG dye and image its fluorescence in breast tissue. Following injection of ICG into the patient, the scanner produces 3D images of the localized concentration of the dye. These images are expected to show increased extravasation and accumulation of the dye in malignant tissue.
Seems no one took notice of it back then! So maybe now some real stuff is coming up. Maybe this 75 orders from chinese government is the upcoming news?!
Posts: 399 | From: Dubai | UAE | Registered: Sep 2005
| IP: Logged |